Biogenvs.Moderna
BIIB vs MRNA · both in Biotech & innovation, part of the Medicine, pharma & life science value chain: Innovation-driven biotech companies focused on novel treatment modalities.
Biogen and Moderna are similar in size by market cap; year to date, Moderna leads (+131.5% vs +13.2%).
Side by side
| BIIB | MRNA | |
|---|---|---|
| Market cap | $29.3B | $27.2B |
| Price | $199.15 | $68.27 |
| Today | +0.1% | −10.8% |
| Return YTD | +13.2% | +131.5% |
| Return 1Y | +47.2% | +99.2% |
| P/E | 21.3 | — |
| P/S | 2.9 | 12.2 |
| P/B | 1.6 | 3.7 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
BiogenBIIB
American biotech company focused on neurological diseases — including Alzheimer's (Leqembi, with Eisai) and MS.
Full BIIB profile →ModernaMRNA
American biotech company based on mRNA technology — known for the covid vaccine, with a pipeline in vaccines and oncology.
Full MRNA profile →More comparisons in Biotech & innovation
See where BIIB and MRNA sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →